Original article Chronic Renal Failure A Neglected Comorbidity of COPD Raffaele Antonelli Incalzi, MD; Andrea Corsonello, MD; Claudio Pedone, MD; Salvatore.

Slides:



Advertisements
Similar presentations
Drug therapy in renal failure Kari Laine, MD, PhD University of Turku & medbase Ltd.
Advertisements

Mrs. Watcharasa Pitug ID The Association between Waist Circumference and Renal Insufficiency among Hypertensive Patients 03/05/58 1.
Associations between Obesity and Depression by Race/Ethnicity and Education among Women: Results from the National Health and Nutrition Examination Survey,
Impact of Preoperative Renal Dysfunction in Patients Undergoing Off- pump vs On-pump Coronary Artery Bypass.
Chapter 1: CKD in the General Population 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
1 Prediabetes Comorbidities and Complications. 2 Common Comorbidities of Prediabetes Obesity CVD Dyslipidemia Hypertension Renal failure Cancer Sleep.
A retrospective cohort study of Childhood post-streptococcal glomerulonephritis as a risk factor for chronic renal disease in later life Andrew V White,
PEBB Disease Burden Report PEBB Board of Directors August 21, 2007 Bdattach.10.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Chapter 2: Identification and Care of Patients With CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Journal Club Alcohol and Health: Current Evidence January–February 2007.
Lesley Stevens MD Tufts-New England Medical Center
HIGH DOSES OF VITAMIN D TO REDUCE EXACERBATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RANDOMIZED TRIAL An Lehouck, PhD; Chantal Mathieu, MD, PhD;
Approach to Advanced Kidney Disease Management in the Elderly Source: Schell JO, Germain MJ, Finkelstein FO, et al. An integrative approach to advanced.
Early Detection and Prevention of Renal Failure Linda Fried, MD, MPH.
Estimated GFR Based on Creatinine and Cystatin C
Hemoglobin A 1c in Hemodialysis Patients Source: Ix JH. Hemoglobin A1c in hemodialysis patients: Should one size fit all? Clin J Am Soc Nephrol. 2010;5:1539–1541.
A significant proportion of diabetic patients develop diabetic nephropathy which can eventually progress to end-stage renal disease despite established.
6 / 5 / RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) ALLHAT.
Primary Aim To compare outcomes of participants with symptoms of stable angina or angina equivalent evaluated with an anatomic imaging strategy using CCTA.
Clinical Appraisal of an Article on Prognosis The Clinical Question Will the prognosis of patients with gout be affected by the administration allupurinol?
Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate, Vascular Disease, and Mortality in Persons With Diabetes in the U.S. Featured Article:
The National Kidney Foundation’s Kidney Early Evaluation Program TM “The Greater New York Experience” Ellen H. Yoshiuchi, MPS Division Program Director.
Dose Adjustment in Renal and Hepatic Disease
PREDICTING AKI IS MORE CHALLENGING AS AGE PROGRESSES Sandra Kane-Gill, PharmD, MSc Associate Professor, School of Pharmacy.
Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less than 75 Years of Age Hiromichi Suzuki, Tsutomu Inoue,Tomohiro.
Routine Care Treatment of Type 2 Diabetes in Germany (DETECT Study) Tatjana Stojakovic 1, Hubert Scharnagl 1, Franz Freisinger 1, Andreas Tiran 1, David.
The management of renal problems in primary care Hugh Gallagher Consultant Nephrologist St Helier Hospital.
Mrs. Watcharasa Pitug ID The Association between Waist Circumference and Renal Insufficiency among Hypertensive Patients 15/10/58 1.
Chronic Kidney Disease (CKD) Epidemiology A NEW EPIDEMIC: CHRONIC KIDNEY DISEASE IN GENERAL POPULATION REAL PREVALENCE AND RELATED FACTORS Josep M. Galceran,
Mrs. Watcharasa Pitug ID The Association between Waist Circumference and Renal Insufficiency among Hypertensive Patients 20/10/58 1.
OTC NSAIDs AND NEPHROTOXICITY Juan Carlos Pelayo, M. D
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Chapter 1: CKD in the General Population 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter 2: Identification and Care of Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
Heart failure and comorbidities
Copyright © 2016 McGraw-Hill Education. All rights reserved. No reproduction or distribution without the prior written consent of McGraw-Hill Education.
Preoperative Hemoglobin A1c and the Occurrence of Atrial Fibrillation Following On-pump Coronary Artery Bypass surgery in Type-2 Diabetic Patients Akbar.
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Lab (5): Renal Function test (RFT) (Part 2) T.A Nouf Alshareef T.A Bahiya Osrah KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab.
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Serum Creatinine Is an Inadequate Screening Test.
Date of download: 5/28/2016 From: New Fibrate Use and Acute Renal Outcomes in Elderly Adults: A Population-Based Study Ann Intern Med. 2012;156(8):
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.
High Coronary Calcification Scores Predict Mortality in Pre-Dialysis CKD Patients Reference: Haas MH. The risk of death in patients with a high coronary.
HYPOTHYROIDISM. INTRODUCTION  Hypothyroidism is defined as a deficiency in thyroid hormone secretion and action that produces a variety of clinical signs.
Risk Involved with Dual RAAS Blockade in Kidney Disease Source: Bakris GL. Dual RAAS blockade is desirable in kidney disease: Con. Kidney Int. 2010;78:546–549.
Kelsey Vonderheide, PA1.  Heart Failure—a large number of conditions affecting the structure and function of the heart that make it difficult for the.
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
The SYMPHONY Trial Reference Reddan DN, et al. Renal function, concomitant medication use and outcomes following acute coronary syndromes. Nephrol Dial.
Prevalence of Chronic Kidney Disease in an Urban Population
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
Interactions Between COPD and Outcomes After Percutaneous Coronary Intervention Tomas Konecny, Krishen Somers, Marek Orban, Yuki Koshino, Ryan J. Lennon,
Efficacy of standard rehabilitation in COPD outpatients with comorbidities 호흡기 내과 R1 박 지 윤 E. Crisafulli, P. Gorgone, B. Vagaggini, M. Pagani, G. Rossi,
Anemia in CKD The TREAT Trial Reference Pfeiffer MA. A trial of Darbepoetin alpha in type II diabetes and chronic kidney disease. N Engl J Med. 2009;361:2019–2032.
بِسْمِ اللَّهِ الرَّحْمَنِ الرَّحِيمِ صدق الله العظيم.
Charles Oo / ASCPT March 06 1 Repeated evaluation of the measured urinary creatinine clearance (CrCL), the predicted creatinine clearance based on Cockcroft-Gault.
신장내과 R4 강혜란 Cardiorenal syndrome (CRS).  Patients with heart failure (HF) who have a reduced GFR -> Mortality ↑  Patients with chronic kidney disease.
Screening System for Hypertension and Diabetes at Primary Care Level
The SPRINT Research Group
Chapter 2: Identification and Care of Patients With CKD
Chapter 1: CKD in the General Population
Andrea Corsonello IRCCS-INRCA Cosenza
The MDRD Study.
Copyright © 2012 American Medical Association. All rights reserved.
Meeting the challenges of the new K/DOQI guidelines
Healthy With HIV.
An example of the Lancet
American Journal of Kidney Diseases
Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.
Presentation transcript:

Original article Chronic Renal Failure A Neglected Comorbidity of COPD Raffaele Antonelli Incalzi, MD; Andrea Corsonello, MD; Claudio Pedone, MD; Salvatore Battaglia, MD; Giuseppe Paglino, MD CHEST 2010 ; 137 : R2 Jang Na Eun

 Chronic renal failure(CRF) is frequently associated with chronic disease such as congestive heart failure and diabetes mellitus When present as a comorbidity, CRF carries negative prognositc implications CRF is often associated with normal serum creatinine concentration, a condition known as unrecognized or concealed CRF  COPD is the seventh most frequent chronic disease and is associated with several comorbidities  COPD is expected to be significantly associated with CRF But, it is unknown to which extent it is associated with CRF Coronary artery disease, which is highly prevalent in patients with COPD is associated with vascular kidney disease Both nicotine and selected heavy metals, which are components of smoke are risk factors for kidney disease INTRODUCTION

 To the best of our knowledge, the association between COPD and chronic renal failure (CRF) has never been assessed  Lean mass is frequently reduced in COPD, and the glomerular filtration rate (GFR) might be depressed in spite of normal serum creatinine (concealed CRF)  We investigated the prevalence and correlates of both concealed and overt CRF in elderly patients with COPD INTRODUCTION

 We used data coming from the Extrapulmonary Consequences of COPD Aimed at exploring extrapulmonary consequences of COPD The diagnosis of COPD confirmed to ATS/ERS guidelines  To be included in the study, patients had to be in a stable condition and with no physical findings or symptoms suggestive of acute exacerbation or therapy modifications in the 30 days before enrollment  In order to verify whether and to what extent COPD is distinctively associated with CRF, the prevalence of CRF in the study population was compared with that obtained in a population of geriatric outpatients free from COPD (control population) METHODS Design Design

 At first visit, patients gave written consent to participate in the study and underwent spirometry and a multidimensional assessment METHODS Design Design

 516 screened patients  27 were excluded because the diagnosis of COPD was not confirmed at the diagnostic work-up, and 5 because of low-quality spirometry results  Given that one or more of the measures needed to compute the GFR were lacking for 128 patients  The final sample included 356 patients  The control population consisted of 290 age- and gender-matched outpatients METHODS Design Design

 The GFR was estimated using the Modification of Diet in Renal Disease (MDRD) Study Group equation  Patients were categorized according to their renal function as having normal renal function (≥GFR 60mL/min/1.73 m2 ), concealed CRF (normal serum creatinine and GFR <60), or overt CRF (increased serum creatinine and GFR <60)  GFR < 60 marks the threshold for moderate renal dysfunction in the Kidney Disease Outcomes Quality Initiative guidelines classification  Serum creatinine was measured by the standardized Jaffe Method The cut off used for serum creatinine was 1.26 mg/dL in men and 1.04 mg/dL in women METHODS Outcomes Outcomes

RESULTS The Study Group - The mean age was 75.4 years (SD 6.1, range 61-92) % of them were women. - The mean serum creatinine concentration was 1.06 mg/dL (SD 0.40) - The mean estimated GFR was 64.2 mL/min/1.73 m 2 (SD 19.2) The Control Group - The mean age (73.9 years, SD 7.9, range 59-89) % of them were women - The mean serum creatinine in the control group was 1.05 (SD 0.55) - The mean estimated GFR was 75.4 mL/min/1.73 m 2 (SD 22.4) - The most common main diseases hypertension (n=5179, 61.7%), muscle-skeletal disease(n=578, 26.9%) cardiovascular disease (n=569, 23.8%), diabetes (n=566, 22.8%) cerebrovascular disease (n=534,11.7%), and dementia (n=533, 11.4%)

RESULTS - The prevalence of normal renal function, concealed CRF, and overt CRF in COPD was 57.0%, 20.8%, and 22.2%, respectively. - The corresponding figures in the control group were 76.6%, 10.0%, and 13.4, respectively (case vs control group: P,.001). - - GFR values were 66.7+/-18.9, 60.7+/-18.3, 61.2+/-19.0, and 59.1+/-18.6 mL/min/1.73 m2 in patients with COPD and an FEV 1 > 80%, 50% to 80%, 30% to 50%, and, 30%, respectively (P =.034) => indicates only a small difference among participants with different degrees of COPD severity

RESULTS - The overall prevalence of CRF was 43.0% in the study group and 23.4% in the control group (P <.001) - Normal serum creatinine was observed in 52.5% of patients with COPD who had a GFR between 30 and 59.9 mL/min/1.73 m2 and in 53.2% of control patients ( P =.923) - while all patients with COPD who had a GFR less than 30 mL/min/1.73 m2 had increased serum creatinine.

RESULTS - Patients with overt CRF had higher overall comorbidity and prevalence of diabetes when compared with those who had normal renal function

RESULTS - COPD and age were significantly associated with both concealed and overt CRF - Diabetes, hypoalbuminemia, and muscle-skeletal diseases were significantly associated with concealed CRF

DISCUSSION The high prevalence of CRF in patients with COPD might have important clinical implications 1. CRF is associated with increased serum levels of inflammatory bio markers and prothrombotic molecules - Thus, CRF might partly mediate the association between COPD and cardio- vascular diseases 2. CRF might help understand the link between COPD and anemia 3. CRF, whether overt or concealed, is a well known risk factor for adverse drug reactions to hydrosoluble drugs. - Indeed, most of the antibiotics commonly used for exacerbated COPD are cleared by the kidney, as also are drugs frequently used to treat comorbid conditions Implications Implications

DISCUSSION 4. Renal a 1-hydroxylase activity decline parallels GFR decline - Depressed renal a 1-hydroxylase activity might add to the list of the factors considered to underlie the association between COPD and Osteoporosis/ fractures Implications Implications

DISCUSSION 1. The GFR was estimated and not directly measured - However, MDRD equation-based GFR is a reliable surrogate for measured GFR in both healthy elderly and diseased populations 2. The present results might not be generalized to the overall population with COPD - Reflecting the epidemiologic characteristics of COPD in the Italian population aged 65 years and older, 48 women were under represented in our population Limitations Limitations

CONCLUSIONS CRF should be considered a common comorbidity of COPD, and it should be screened for because its recognition might either directly affect clinical practice or have prognostic implications CRF is highly prevalent in patients with COPD, even with normal serum creatinine, and might contribute to explaining selected conditions such as anemia that are frequent complications of COPD